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The effect of changes in core body temperature on
the QT interval in beagle dogs: a previously ignored
phenomenon, with a method for correction
HJ van der Linde, B Van Deuren, A Teisman, R Towart and DJ Gallacher
Division of Janssen Pharmaceutica NV, Center of Excellence for Cardiovascular Safety Research, Johnson & Johnson Pharmaceutical
Research and Development, Beerse, Belgium
Background and purpose: Body core temperature (Tc) changes affect the QT interval, but correction for this has not been
systematically investigated. It may be important to correct QT intervals for drug-induced changes in Tc.
Experimental approach: Anaesthetized beagle dogs were artificially cooled (34.21C) or warmed (42.11C). The relationship
between corrected QT intervals (QTcV; QT interval corrected according to the Van de Water formula) and Tc was analysed.
This relationship was also examined in conscious dogs where Tc was increased by exercise.
Key results: When QTcV intervals were plotted against changes in Tc, linear correlations were observed in all individual dogs.
The slopes did not significantly differ between cooling ( 14.85±2.08) or heating ( 13.12±3.46) protocols. We propose a
correction formula to compensate for the influence of Tc changes and standardize the QTcV duration to 37.51C: QTcVcT
(QTcV corrected for changes in core temperature)¼QTcV–14 (37.5 – Tc). Furthermore, cooled dogs were re-warmed (from
34.2 to 40.01C) and marked QTcV shortening ( 29%) was induced. After Tc correction, using the above formula, this
decrease was abolished. In these re-warmed dogs, we observed significant increases in T-wave amplitude and in serum [K
þ]
levels. No arrhythmias or increase in pro-arrhythmic biomarkers were observed. In exercising dogs, the above formula
completely compensated QTcV for the temperature increase.
Conclusions and implications: This study shows the importance of correcting QTcV intervals for changes in Tc, to avoid
misleading interpretations of apparent QTcV interval changes. We recommend that all ICH S7A, conscious animal safety
studies should routinely measure core body temperature and correct QTcV appropriately, if body temperature and heart rate
changes are observed.
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Keywords: hyperthermia; hypothermia; QT interval; dog; correction formula; hyperkalaemia; hypokalaemia; drug-induced
temperature changes
Abbreviations: ICH, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals
for Human Use; QTcV, QT interval corrected according to the Van de Water formula; QTcVcT, QTcV corrected
for changes in core temperature
Introduction
The QT interval of the ECG is an indirect measurement of
the time taken for the ventricles to depolarize and repolarize.
Assessment of the QT interval is of clinical importance
because prolongation of repolarization is often associated
with conditions such as electrical instability and sudden
cardiac death (Algra et al., 1991), but can also be indicative of
the pro-arrhythmic activity for new chemical entities (De
Clerck et al., 2002). As the QT interval is dependent on the
length of the cardiac cycle, this interval has to be corrected
for changes in heart rate (HR) (Fridericia, 1920; Van De Water
et al., 1989). In addition to HR, changes in core temperature
(Tc) can also influence the ventricular repolarization
time (Alhaddad et al., 2000). However, Tc is rarely measured
in Good Laboratory Practice safety studies, even though
most radio-telemetry devices used in such studies have a
temperature measurement function, and a method for
correcting this phenomenon is currently lacking. Tc is
normally maintained within narrow well-defined limits,
but under certain circumstances, it can be increased, for
example, by pharmacological agents (White and Simpson,
1984; Nimmo et al., 1993; serotonin syndrome, see
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or by malignant hyperthermia, and can be decreased,f o r
example, during surgery, postoperative recovery and illness. If
the QTc interval is used to diagnose prolongation of repolariza-
tion during hypo- or hyperthermic situations within drug safety
evaluations, then the sole use of a standard QT correction
formula may be inadequate and thus misleading. Over-correc-
tion or under-correction may lead to artificial results, when
body temperature is changed. Although the underlying me-
chanisms of QT interval changes associated with hypo- and
hyperthermia are not fully understood, it is known that serum
potassium concentrations can increase during hyperthermia in
different species (Spurr and Barlow, 1959; Sprung et al., 1991),
and during malignant hyperthermia in humans (Wappler et al.,
2000). However, what role these electrolyte alterations have on
cardiac repolarization during temperature change is also
unknown, as action potential durations are also increased in
in vitro studies—using tissue from guinea-pigs (Lathrop et al.,
1998), rabbits (unpublished data) and pigs (Roscher et al., 2001),
where electrolyte levels are controlled through perfusion of
physiological salt solutions. The aim of the present study was to
explore the changes of QT interval (QTcV interval; QT interval
corrected according to the Van de Water formula), under
controlled hypothermic and hyperthermic conditions in anaes-
thetized dogs, and to propose a mathematical formula to correct
the QTcV interval for changes in body temperature. The formula
was tested in the same group of dogs, to mimic clinical
situations, such as re-warming (analogous to procedures for
postoperative or cooled patients) and re-cooling (procedures for
heat stroke or fever). Furthermore, we have challenged this
formula during exercise tests in conscious telemetered beagle
dogs, as exercise also increases body temperature (Febbraio et al.,
1996) and none of the existing formulae correct the QT interval
properly during exercise (Aytemir et al., 1999; Benatar and
Decraene, 2001; Newbold et al., 2007). The applicability of the
formula in dogs and humans under different circumstances was
further investigated by a review of published data.
Methods
This investigation was conducted in accordance with ‘the
provision of the European Convention’ on the protection of
vertebrate animals, which are used for experimental and other
scientific purposes, and with ‘the Appendices A and B’, made at
Strasbourg on 18 March 1986 (Belgian Act of 18 October 1991).
Animals
Sixteen adult beagle dogs (eight males and eight females)
were used in this study, their body weight averaging 11.9kg
(range: 9.8–13.8kg) and their age averaging 12 months
(range: 10–17 months). All dogs were examined before use
and found to be healthy and active. Food (but not water) was
withheld for at least 12h prior to anaesthesia and cardio-
vascular experimentation.
Anaesthesia and measured parameters
Briefly, under total intravenous anaesthesia induced by
0.075mgkg
 1 lofentanil, 0.0015mgkg
 1 scopolamine (Janssen
Pharmaceutica, Johnson & Johnson Pharmaceutical R&D
(J&J PRD), Beerse, Belgium) and 1.0mgkg
 1 succinylcholine
(Myoplegine; Christiaens NV, Brussels, Belgium) and main-
tained by infusion of etomidate 1.5mgkg
 1h
 1 (J&J PRD),
dogs were ventilated with 30% oxygen in pressurized air to
normocapnia (PaCO2 between 30 and 50mmHg). The ECG
(ECG lead II limb leads; Emka, Paris, France) was continu-
ously monitored (sampling frequency, 1000Hz) and an open
lumen catheter was placed into the femoral artery and
positioned close to the heart to obtain blood samples for
blood gas analysis (ABL700; Radiometer, Brønshøj,
Denmark), to monitor stability of the preparation over the
course of the experiment.
Heart rate (b.p.m.) was calculated from the pressure signal
and the QT interval (measured from the onset of the QRS to
the end of the T wave; ms) was taken from the lead II ECG,
from which the T-wave morphology was also examined.
Furthermore, the QT intervals were corrected for changes in
HR according to the Van de Water formula (QTcV; ms, Van
de Water et al., 1989). Body Tc (1C) was measured con-
tinuously from within the right ventricle of the heart and all
signals and parameters were automatically analysed
(Notocord-Hem 3.3; Croissy, France) and represented in an
Excel file as median values over 1min.
Study protocol
Eight dogs (five males and three females) were observed
during controlled changes of Tc and were divided into two
subgroups to investigate a decrease and an increase in Tc.
Four dogs were cooled to 341C by a blanket of ice and a cold
air fan, and another group of four dogs was warmed to 421C
using a heating plate in combination with a heating lamp. At
the end of the study, the results from each group were
pooled, to achieve data over a range of temperatures, from
normothermia to hypothermia (from 37.5 to 341C), and
from normothermia to hyperthermia (from 37.5 to 421C).
Both groups were compared with a set of eight control dogs
(three males and five females), evaluated with a constant Tc
of approximately 37.51C over the same time period. The
cooled dogs were thereafter slowly re-warmed to 401Cb ya
heating plate in combination with a heating lamp and the
heated dogs were slowly re-cooled to 371C by turning off all
heating equipment. During the re-warming and re-cooling
procedures, special attention was given to T-wave morphology,
and arterial blood samples were obtained every 15min in
both groups to determine the plasma concentration of
potassium.
Calculation of the correction formula
To calculate the temperature correction formula, we plotted
the QTcV intervals against Tc (median value of every minute)
of all individual cooled (from 37.7 to 34.21C) and heated
(from 37.3 to 42.11C) dogs. As the relationship between the
parameters appeared to be linear (Figure 1a) for both groups,
and the R
2 for a linear relationship was highly significant in
all dogs (Table 2), the mean slope of the linear relationship of
both parameters in all dogs was used to derive the formula.
To validate the formula, we corrected the QTcV intervals for
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core temperature) to achieve a horizontal line in the
QTcVcT/Tc plots in four dogs with a Tc range from 34 to
401C. The linear regression line of these plots should have a
slope and correlation coefficient (R
2) close to zero.
Validation of the correction formula
To validate and check the applicability of the correction
formula, it was used in the same dogs after re-warming and
re-cooling. Furthermore, we checked the formula in freely
moving telemetered beagle dogs before and after an exercise
test. In this study, 36 female dogs were telemetered (ITS
(International Telemetry Systems, Dexter, MI, USA) T27F-11)
to measure ECG and Tc, at rest and during a speed-increasing
protocol of 40min (from walking to running against
15kmh
 1) on a roller band treadmill. During the study, Tc,
HR and QT were monitored and after the study QTcV and
QTcVcT were calculated. In addition, we conducted a
literature survey to investigate published changes in Tc and
QTc in dogs and man. To achieve comparable slopes we
corrected the QT interval, where necessary, in the dog studies
by the de Van de Water formula, and by the Fridericia
formula in human studies.
Statistical analysis
Pooled data were expressed as mean±standard deviation.
Intergroup comparisons were made with ANOVA Dunnett’s
test on repeated measures (WINKS SDA Software, Cedar Hill,
USA). Comparisons within a group were made with a paired
t-test (Microsoft Excel 2000). Linear regression and correla-
tion analysis were made using Pearson’s correlation coeffi-
cient (WINKS SDA Software, Cedar Hill, USA). A two-tailed
Po0.05 was considered statistically significant.
Results
In this study, we used two groups of dogs, eight dogs that
were cooled (n¼4) or heated (n¼4) and eight dogs, which
were kept at basal Tc, as a time control group. There were no
notable differences between both treated and control groups
in gender (male/female¼5/3 versus 3/5, respectively), body
weight (11.7±1.4 versus 11.9±1.0kg, respectively), age
(12±2 versus 12±1 months, respectively), basal Tc
(37.5±1.3 versus 37.8±1.21C, respectively), basal HR
(88±33 versus 72±13b.p.m., respectively), basal QT
(240±19 versus 257±22ms, respectively) and basal QTcV
(264±4 versus 261±18ms, respectively).
In the pooled averaged data (Table 1) from the cooled
dogs, the decrease of Tc (P¼0.003) within 63±13min
induced a decrease in HR (P¼0.014), prolongation of QT
interval (P¼0.007) and QTcV interval (P¼0.002). Table 1
also shows that in pooled averaged data from the heated
dogs, the increase of Tc (P¼0.004) induced an inconsistent
increase in HR (P¼0.137), but a clear shortening of QT
(P¼0.005) and QTcV intervals (P¼0.006). Neither the
prolongation of QTcV on cooling nor the shortening on
warming were associated with arrhythmias or pro-arrhythmic
biomarkers, such as extrasystoles, early after depolarisations
or enhanced J waves (data not shown). The values of Tc, QT
and QTcV of the treated dogs were significantly different
from the control group over the same time frame. During
this time course, no significantly different changes of Tc, HR,
QT or QTcV from baseline (time¼0) were evident in the
control group (Table 1).
To investigate the relationship between the duration of the
QTcV interval and the Tc, the slope and the correlation
coefficient (R
2) of the relationship between QTcV interval
and Tc, of all individual dogs (cooled and heated), were
examined (Table 2). Over the range of temperatures exam-
ined (34.2–42.11C), the relation between QTcV and Tc
appeared to be linear (Figure 1a); therefore, linear regression
was therefore used. No significant difference (P¼0.242) was
observed between the slopes in the two procedures: cooling
the dogs resulted in a slope of  14.85±2.08 with an R
2 of
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Figure 1 (a) Plot of core temperature (Tc) against QTcV interval
(QTcV) of all individual dogs (n¼8); cooled (open circles) and
heated (closed circles). Regression analysis showed a good linear
correlation over all dogs (slope¼ 14.06, R
2¼0.88 and Po0.001).
(b) Plot of Tc against QTcVcT interval (QTcVcT) of all individual dogs
(n¼8), linear correlation with slope¼ 0.06, R
2¼0.0001 and
P¼0.758.
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 13.12±3.46 with an R
2 of 0.97±0.01. This gave an average
slope for cooling and heating of  14.0, that is, a decrease or
increase in Tc of 11C induced an increase or decrease in the
QTcV interval of 14ms.
To correct the duration of the QTcV interval for changes in
Tc to a temperature of 37.51C (normal body temperature in
conscious telemetered dogs), the following formula was
derived:
QTcVcT ¼ QTcV   14ð37:5   TcÞ
Plotting QTcVcT values against Tc (Figure 1b) produced a
horizontal regression line with a slope of  0.06 and without
any correlation (R
2¼0.0001, P¼0.758).
The four cooled dogs were re-warmed (from 34 to 401C;
Table 3, rows A) and showed not only a clear decrease in QT
interval (P¼0.002) and QTcV (P¼0.002) without significant
changes in HR (P¼0.684) or QTcVcT (P¼0.326), but we
observed an increase of the small T wave in the cooled dog to
a tall, narrow based, peaked and symmetrical (‘tented’) T
wave (see Webster et al., 2002) at a high Tc (from 0.09±0.08
to 0.52±0.21mV, P¼0.024; Figure 2). Furthermore, an
increase in serum potassium concentrations (from 3.1±0.3
to 4.3±0.2mmolL
 1, P¼0.004) was noted throughout this
temperature range. The slope and the correlation coefficient
(R
2) of the linear relationship (Po0.001) between QTcV time
and Tc of pooled data in this group are shown in Figure 3a.
The four heated dogs were then cooled (Table 3, rows B),
but now showed inconsistent changes in QT interval
(P¼0.141) or QTcV (P¼0.071), and the increased HR
(P¼0.770) did not return to normothermic baseline values.
Furthermore, the increased serum potassium concentrations
did not return to baseline values (P¼0.724), only the T-wave
amplitude was slightly decreased (P¼0.269). The slope and
the correlation coefficient (R
2) of the relationship between
QTcV time and Tc of pooled data in this group after re-
cooling from 421C were now much lower (Figure 3b).
Indeed, after re-cooling these four warmed dogs to normal
Tc, two of them showed a further increase in serum potassium
concentration (from 4.9 and 4.7 to 6.7 and 5.1mmolL
 1,
respectively), and QTcV did not return to baseline values
(from 206 and 208ms to 205 and 239ms; slopes:  1.31 and
 0.02 and R
2: 0.4 and 0.15, respectively). The other two dogs
showed only partial decreases in serum potassium concen-
trations (from 5.3 and 4.4mmolL
 1 to 4.6 and 3.8mmolL
 1,
Table 2 DTc, DQTcV, slopes and R
2 values of all individual dogs; cooled
(n¼4) and heated (n¼4)
Dog Gender DTc (1C) DQTcV (ms) Slope R
2
Cooled
1 Male  3.2 þ66  16.33 0.91
2 Male  2.5 þ56  16.53 0.90
3 Male  3.8 þ49  14.47 0.89
4 Female  4.2 þ40  12.06 0.88
Heated
5 Male þ6.5  65  9.71 0.95
6 Female þ4.8  34  17.11 0.96
7 Male þ3.8  45  10.82 0.97
8 Female þ4.4  61  14.85 0.98
Table 1 Core body temperature (Tc), heart rate (HR), QT interval (QT)
and QTcV interval (QTcV) in cooled dogs (n¼4), heated dogs (n¼4)
and control dogs (n¼8)
Time (min) Tc (1C) HR (b.p.m.) QT (ms) QTcV (ms)
Cooled
0 37.7±0.8 96±24
z 241±12 269±9
63±13 34.2±0.3
wz 61±13
w 323±35
wz 321±19
wz
Heated
0 37.3±1.0 80±24 239±13 259±9
148±41 42.1±0.8
wz 132±71
z 171±27
wz 208±11
wz
Control
0 37.7±1.2 72±13 257±22 264±20
60 37.6±1.1 76±12 252±18 265±10
150 37.5±0.9 71±11 256±17 262±20
Values are expressed as mean±s.d.
Comparisons within a group:
wP-valueo0.05; t-test (two sided, paired).
Intergroup comparisons:
zP-valueo0.05; ANOVA/Dunnett’s test (two sided,
unpaired).
Table 3 Core temperature (Tc), heart rate (HR), QT interval (QT) and QTcV interval (QTcV), temperature corrected QTcV (QTcVcT), T-wave amplitude
(T wave) and serum potassium concentration [K
þ] in re-warmed dogs (A; n¼4), warmed and subsequently re-cooled dogs (B; n¼4) and control dogs
(C; n¼8)
Tc (1C) HR (b.p.m.) QT (ms) QTcV (ms) QTcVcT (ms) T wave (mV) [K
þ] (mmolL
 1)
A
34.2±0.3
z 61±12 326±33
z 324±15
z 277±17 0.09±0.08
z 3.1±0.3
40.0±0.4
wz 65±17 227±17
wz 229±7
wz 264±8 0.52±0.21
w 4.3±0.2
wz
B
42.1±0.8
z 124±58
z 174±22
z 211±7
z 275±13 0.60±0.40 4.8±0.4
z
36.8±0.2
w 130±52
z 198±43
z 238±23 228±22
wz 0.35±0.31 5.1±1.2
z
C
37.7±1.2 72±13 257±22 264±20 264±20 0.35±0.11 3.4±0.4
37.5±0.9 72±10 253±14 261±20 261±20 0.42±0.16 3.6±0.3
Values are expressed as mean±s.d.
Comparisons within a group:
wP-valueo0.05; t-test (two sided, paired).
Intergroup comparisons:
zP-valueo0.05; ANOVA/Dunnett’s test (two sided, unpaired).
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values (from 221 and 207ms to 255 and 253ms; slopes:
 7.53 and  8.07 and R
2: 0.97 and 0.93, respectively).
In the normothermic control group, as expected, no
significant changes were measured in HR, QT, QTcV, etc.,
during a constant Tc of 37.7 to 37.51C over the same time
period as the cooling and warming experiments reported
above (Table 3, rows C). In addition, experiments with
atrially paced normothermic dogs showed that QTcV was not
significantly altered at rates up to 120b.p.m. (unpublished
data).
In freely moving telemetered dogs (Table 4), the exercise
procedure (from walking to running over 40min) induced a
small increase in Tc (Po0.05) and HR (Po0.05), and a
decrease in QT (Po0.05). The rate-correcting formula by Van
de Water did not fully correct for HR: exercise induced a
decrease in QTcV (Po0.05) and showed a slope of  15.7.
Using our Tc correction formula, we calculated a fully HR-
and body temperature-independent parameter, QTcVcT of
244±11ms (P¼0.824).
Estimated slopes of changes in Tc and QTc in dogs and
humans, extracted from already published data showed
similar results compared to our own data (Table 5). Cooling,
heating, re-warming or fever induced changes in Tc, but all
studies showed after calculation (DQTc/DTc) an estimated
slope between  11.0 and  17.1.
Discussion and conclusions
In this study, we were able to cool the Tc of anaesthetized
dogs to 34.21C (hypothermic conditions), and to warm the
Tc to 42.11C (hyperthermic conditions) with only minor
changes in HR. Hypothermia prolonged the QT interval and
conversely, hyperthermia shortened the QT interval, both
without obvious pro-arrhythmic signs. The reliable Van de
Water formula (King et al., 2006), often used in dog studies,
did not properly correct these large changes in QT intervals.
The prolongation of the QT interval in hypothermic
conditions has been previously described before in dogs
(Beyda et al., 1960) and humans (Mattu et al., 2002; Aslam
et al., 2006), but the shortening of the QT interval in
hyperthermic conditions has been poorly studied (Geller
et al., 1952). The relationship between QTcV and Tc over the
temperature range investigated, cooling (from 37.7 to
34.21C) and heating (from 37.3 to 42.11C) in this study
was linear for all individual dogs (R
2 between 0.88 and 0.98),
and a slope was calculated, showing an average decrease of
14ms per degree change. The correction formula for the Tc
was calculated and validated for different circumstances
(re-warming, re-cooling and exercise), for different models
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Figure 2 Example of T-wave morphology changes during 34.71C
(A), 37.01C (B) and 41.31C (C). Note the narrow based, peaked and
symmetric T wave (so-called tented T wave) at high core
temperature.
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Figure 3 Plot of core temperature (Tc) against QTcV interval
(QTcV) of (a) re-warmed dogs (n¼4); linear correlation with
slope¼ 17.02, R
2¼0.85 and Po0.001 and of (b) re-cooled dogs
(n¼4); linear correlation with slope¼ 4.66, R
2¼0.26 and
Po0.001.
Table 4 Core temperature (Tc), heart rate (HR), QT interval (QT) and
QTcV interval (QTcV), temperature corrected QTcV (QTcVcT), in freely
moving telemetered beagle dogs (n¼36) at rest and after exercise
Tc (1C) HR (b.p.m.) QT (ms) QTcV (ms) QTcVcT (ms)
Rest 37.6±0.6 109±23 206±16 244±14 244±16
Exercise 38.3±0.8
w 152±22
w 181±14
w 233±10
w 244±11
Values are expressed as mean±s.d.
wP-valueo0.05; t-test (two sided, paired).
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literature (dogs and humans).
The mechanisms of temperature change on the ECG in
general, and on the QT interval in particular, are almost
certainly multi-factorial. Metabolic rate varies with body
temperature in both homoeotherms and poikilotherms, and
affects most bodily processes. Biologists are familiar with the
marked changes in contractility and spontaneous activity in
isolated organs produced by different bath temperatures (for
example, Smith et al., 1951). However, under such condi-
tions in vitro, extracellular ionic concentrations are constant.
In whole animals, however, other factors may also be
involved. It has been reported that hypothermia is accom-
panied by hypokalaemia, a shift of potassium from extra-
cellular to intracellular or extra-vascular spaces (Koht et al.,
1983). Hypokalaemia causes a decrease in the resting
membrane potential in ventricular cells, reduces the T-wave
amplitude and induces QT prolongation (Slovis and Jenkins,
2002). Other investigators have noted that enhancement of
the body temperature, induced by exercise-dependent
malignant hyperthermia (Wappler et al., 2000), or by
artificially induced hyperthermia in dogs (Spurr and Barlow,
1959), can lead to an increase in serum potassium concen-
trations. Hyperkalaemic states have an effect on the ECG,
and the early signs are tall, narrow based, peaked and
symmetric T waves (so called ‘tented’ T waves), and the QT
interval is decreased (Webster et al., 2002). In our study, we
found increases in Tc to be associated with increases in
T-wave amplitudes and in serum potassium concentration in
re-warmed dogs. As such, changes in serum potassium
concentrations could be considered to contribute towards
the effects on QTcV reported here. However, it is important
to note that the changes in serum potassium concentrations
do not affect the QTcV/Tc slope in our anaesthetized dogs,
and the proposed formula fully corrected the QTcV interval
for the increase in Tc. Indeed, action potential durations
have also been shown to be markedly altered in vitro in
guinea-pigs (Duker et al., 1987; Lathrop et al., 1998), rabbits
(unpublished data from Langendorff hearts) and pigs
(Roscher et al., 2001), where electrolyte levels are controlled
through perfused physiological salt solutions.
The small slopes and lack of linearity between Tc and QTc
in dogs warmed to over 421C and then re-cooled to 36.81C
are probably caused by the very high body temperatures
induced in these dogs. Indeed, it was noted that when the
body temperature was raised to over 421C, the return to
normothermia was associated with lower QT intervals, and
higher HRs, serum potassium concentration and T waves in
these dogs. The critical thermal maximum (CTM) in dogs is
between 43.0 and 44.51C, and in heatstroke models dogs die
after CTM has been reached for a longer period (Bynum et al.,
1977), so these temperatures are by themselves pathological.
In our study, four dogs were increased to a Tc close to the
CTM. During re-cooling to normal Tc, two of them showed
only a partial decrease in serum potassium concentrations,
and QTcV did not fully increase to baseline values. The other
two dogs showed a further increase in serum potassium
concentrations, and the increases in QTcV were even smaller
than those seen in the two dogs whose potassium concen-
trations decreased.
It should be emphasized that these apparently pathologi-
cal influences of high temperature on serum potassium
concentrations and on QTcV intervals (Table 3 (rows B) and
Figure 3b) were obtained subsequent to the data shown in
Tables 1 and 2, which were used to derive the proposed
correction factor.
As mentioned above, the effects of drug-induced tempera-
ture changes on QT (QTc) have been poorly studied, and to
our knowledge, have not been systematically examined
within cardiovascular safety studies. However, there are
many existing drugs that are known to affect body
temperature (Clark, 1979; Clark and Clark, 1980a,b), and
there is increasing interest in certain classes of develop-
mental drugs (for example, 5-HT1A receptor agonists (Seletti
et al., 1995), dopamine D3 receptor agonists (Boulay et al.,
1998), TRPV1 antagonists (Szallasi et al., 2007)) and biologic
drugs (interferon-alpha (Kentner et al., 2006), interleukin
(Gatti et al., 2002)), which have documented effects on body
temperature homoeostasis. Therefore, any drug that affects
Tc can be expected to have temperature effects on QTc
(B14ms per degree) whether or not the drug has actual
direct effects on cardiac repolarization. Thus in a CV safety
study, a new chemical entity with no effect on IKr (HERG)
can easily appear to prolong QTc interval, simply by a
decrease in body temperature. Conversely, the effects of a
new chemical entity, with a direct blocking effect on IKr,
could be masked by the shortening of QTc intervals resulting
from an increase in body temperature.
Table 5 Estimated slopes of changes in body temperature (Tc) and QTc in dogs and humans, extracted from published data
Treatment Species Tc (1C) range QTc (ms) range Estimated slope Literature
Heated Dog 38.0–41.5 276–233  12.3 Geller et al. (1952)
Cooled Human 36.0–29.0 460–570  15.7 Fleming and Muir (1956)
Cooled Human 37.0–31.0 353–435  13.7 Hicks et al. (1956)
Cooled Dog 38.0–32.0 248–329  13.4 West et al. (1959)
Cooled Dog 38.4–26.7 340–490  12.8 Beyda et al. (1960)
Cooled Infant 37.0–30.0 388–508  17.1 Wakusawa et al. (1977)
Fever Human 37.2–39.4 411–373  16.9 Karjalainen and Viitasalo (1986)
Re-warmed Human 29.4–33.3 545–483  16.0 Mattu et al. (2002)
Re-warmed Human 25.6–30.7 609–522  17.0 Mattu et al. (2002)
Cooled Infant 37.0–34.0 431–465  11.3 Horan et al. (2007)
Re-warmed Human 31.7–35.8 505–460  11.0 Yaganti et al. (2007)
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can affect Tc (Tontodonati et al., 2007). In conscious
animal safety studies, modern technology (for example, ITS
systems) now allows accurate online measurement of Tc and
locomotor activity in addition to cardiovascular parameters,
but the former parameters are rarely examined in conven-
tional study protocols. Our study in conscious, exercising
dogs showed an apparent shortening of QTcV by 11ms
(4.5%), which was fully compensated by taking the Tc rise
into account. This emphasizes the importance of investigat-
ing possible drug-induced effects on locomotor activity
as well as on Tc, both to examine a new drug’s safety
profile, and to distinguish between direct and indirect
changes on Tc.
Limitations
First, the results were achieved in the anaesthetized animal,
so may not be directly applicable to the conscious state using
a similar method. However, both the exercise study with
freely moving telemetered dogs showed a complete correc-
tion for HR and temperature by the proposed correction
formula, and the results recalculated from literature studies
tabulated in this study are qualitatively supportive of the
results reported—in animals and in humans—in cases of
both hypo- and hyperthermia.
Second, we have investigated this relationship over an
adequate range for drug- or exercise-induced changes in Tc
(B34–421C), but it may not be valid for lower temperatures.
The apparently pathological body changes (for example,
massive increase in serum potassium concentrations, irre-
versible effects on ECG) seen in some dogs warmed to near
the CTM of B431C, should be taken into account and
avoided in further studies.
Lastly, although this correction formula has been obtained
in anaesthetized dogs, and validated in one example in freely
moving exercising dogs, it may not be appropriate for other
species (including humans) and circumstances. Further
studies will be required to check and/or improve this
formula. In conclusion, this study has demonstrated a
marked dependence of the QT interval (QTc) on temperature
in the anaesthetized dog, and has determined for the first
time, to our knowledge, a correction formula to allow
normalization to normothermic values. The use of this
correction formula was validated in different situations, such
as re-warming and re-cooling, and in exercise tests in
conscious telemetered beagle dogs, and the applicability of
the formula in dogs and humans under different circum-
stances was further investigated by a comparison with
published data.
Temperature is rarely studied in safety studies, and our
findings suggest that
(1) Some drugs may be incorrectly classified as having direct
effects on repolarization (QT) if they also change body
temperature by direct or indirect (for example, by
changing locomotor activity) mechanisms;
(2) Conversely, direct QTeffects may be missed when testing
drugs that change body temperature;
(3) Altered plasma potassium levels are found in association
with the phenomena reported, and
(4) Identification or classification of patients (for example,
long QT syndrome) by exercise tests may be improved by
using a more accurate correction formula.
We recommend that all ICH S7A, conscious animal, safety
studies should routinely measure body Tc and locomotor
activity (which may indirectly influence Tc), and correct QTc
using an appropriate formula if body temperature changes
are detected. This will help to avoid generating misleading
data and to explain false-positive or -negative results. Indeed,
correction for temperature changes on the QT interval
should also be considered in human trials, especially where
stress testing is incorporated into the design, and repeated-
dose large animal toxicological studies.
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